MESP1 | Mesoderm posterior 1 homolog (mouse) | Transcription factors
| | | | | Tissue enhanced |
MKX | Mohawk homeobox | Transcription factors
| | | | | Tissue enhanced |
MYH3 | Myosin, heavy chain 3, skeletal muscle, embryonic | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
NLRP9 | NLR family, pyrin domain containing 9 | | | | | | Tissue enhanced |
NPPC | Natriuretic peptide C | Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
OPRK1 | Opioid receptor, kappa 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
OR51E1 | Olfactory receptor, family 51, subfamily E, member 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RX2 | Purinergic receptor P2X, ligand-gated ion channel, 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
PCP4 | Purkinje cell protein 4 | | | | | | Tissue enhanced |
PDE11A | Phosphodiesterase 11A | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
PMEPA1 | Prostate transmembrane protein, androgen induced 1 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PRDM8 | PR domain containing 8 | Transcription factors
| | | | | Tissue enhanced |
PRKG2 | Protein kinase, cGMP-dependent, type II | Enzymes
| | | | | Tissue enhanced |
RAB3B | RAB3B, member RAS oncogene family | | | | | | Tissue enhanced |
RFPL1 | Ret finger protein-like 1 | | | | | | Tissue enhanced |
RP11-1102P16.1 | Uncharacterized protein | | | | | | Tissue enhanced |
RP11-481A20.11 | Protein LOC101060662 | | | | | | Tissue enhanced |
RPE65 | Retinal pigment epithelium-specific protein 65kDa | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
SALL3 | Spalt-like transcription factor 3 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
SELE | Selectin E | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SHISA9 | Shisa family member 9 | Predicted membrane proteins
| | | | | Tissue enhanced |
SHROOM1 | Shroom family member 1 | | | | | | Tissue enhanced |
SLC14A1 | Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | Blood group antigen proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC15A2 | Solute carrier family 15 (oligopeptide transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A8 | Solute carrier family 16 (monocarboxylate transporter), member 8 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A12 | Solute carrier family 2 (facilitated glucose transporter), member 12 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC30A4 | Solute carrier family 30 (zinc transporter), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC35F4 | Solute carrier family 35, member F4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SPDEF | SAM pointed domain containing ETS transcription factor | Transcription factors
| | | | | Tissue enhanced |
STAC | SH3 and cysteine rich domain | | | | | | Tissue enhanced |
STEAP1 | Six transmembrane epithelial antigen of the prostate 1 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SYT7 | Synaptotagmin VII | Predicted membrane proteins
| | | | | Tissue enhanced |
TMPRSS2 | Transmembrane protease, serine 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
TMSB15A | Thymosin beta 15a | Cytoskeleton related proteins
| | | | | Tissue enhanced |
TULP1 | Tubby like protein 1 | Disease related genes
| | | | | Tissue enhanced |
UNC5D | Unc-5 homolog D (C. elegans) | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
VSTM2A | V-set and transmembrane domain containing 2A | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
VWA1 | Von Willebrand factor A domain containing 1 | Predicted secreted proteins
| | | | | Tissue enhanced |